Connecticut Children’s Division of Pediatric Neurology is engaged in several clinical trials.
Clinical trials are a key research tool for advancing medical education and clinical care. Most commonly, clinical trials are used to test the safety and effectiveness of drugs and devices. Clinical trials are led by research teams that can include doctors and other medical professionals.
Current clinical trials include:
Primary Investigator: Jennifer Madan Cohen, MD
Study Title: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in children and adults
Study code: GWEP1414
Primary Investigator: Jennifer Madan Cohen, MD
Study Title: An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox Gastaut Syndromes
Study code: GWEP1415
Primary Investigator: Jennifer Madan Cohen, MD
Study Title: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome
Study code: GWEP1424